Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer.
Dose evaluation of inter- and intra-fraction prostate motion in extremely hypofractionated intensity-modulated proton therapy for prostate cancer.
复制标题
DOI:
10.1016/j.phro.2023.100474
复制
发表时间:
2023-07
影响因子:
--
通讯作者:
Aluwini, Shafak
中科院分区:
文献类型:
--
作者:
Feng, Sen-Quan;Brouwer, Charlotte L.;Korevaar, Erik W.;Vapiwala, Neha;Wang, Ken Kang-Hsin;Deville, Curtiland, Jr.;Langendijk, Johannes A.;Both, Stefan;Aluwini, Shafak
关键词:
Synthetic computed tomography images were used to simulate real-time prostate position A 4D simulation method of intra-fractional prostate motion was developed Prostate motion had minimal dose impact to robustly optimized proton therapy Inter- and intra-fractional prostate motion can deteriorate the dose distribution in extremely hypofractionated intensity-modulated proton therapy. We used verification CTs and prostate motion data calculated from 1024 intra-fractional prostate motion records to develop a voxel-wise based 4-dimensional method, which had a time resolution of 1 s, to assess the dose impact of prostate motion. An example of 100 fractional simulations revealed that motion had minimal impact on planning dose, the accumulated dose in 95 % of the scenarios fulfilled the clinical goals for target coverage (D95 > 37.5 Gy). This method can serve as a complementary measure in clinical setting to guarantee plan quality.
登录
查看更多内容
DOI:
10.7759/cureus.2442
发表时间:
2018-04-06
期刊:
Cureus
影响因子:
--
作者:
Hegde JV;Cao M;Yu VY;Kishan AU;Shaverdian N;Lamb J;Steinberg ML
通讯作者:
Steinberg ML
DOI:
10.1016/j.ijrobp.2006.10.026
发表时间:
2007-03-15
影响因子:
7
作者:
Kupelian, Patrick;Willoughby, Twyla;Levine, Lisa
通讯作者:
Levine, Lisa
影响因子:
5.7
作者:
Ammazzalorso, Filippo;Graef, Sebastian;Jelen, Urszula
通讯作者:
Jelen, Urszula
影响因子:
3.6
作者:
Juneja, Prabhjot;Kneebone, Andrew;Eade, Thomas
通讯作者:
Eade, Thomas
影响因子:
51.1
作者:
Dearnaley, David P.;Jovic, Gordana;Sydes, Matthew R.
通讯作者:
Sydes, Matthew R.